Cardiovascular problems in pregnancy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000628:therapy; D003327:Coronary Disease / Q000628:therapy*; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006330:Heart Defects, Congenital / Q000628:therapy*; D006349:Heart Valve Diseases / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy*; D011644:Puerperal Disorders / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D004232:Diuretics; D004077:Digoxin